Wolverine Blend 5mg
Wolverine Blend (BPC-157 / TB-500) 5mg
Blend - BPC-157 and TB-500 sequences
Overview
The Wolverine Blend 5mg is a lower-quantity formulation of the same BPC-157/TB-500 combination available in the 10mg vial. The synergistic rationale remains identical: BPC-157 promotes angiogenesis through VEGF upregulation and nitric oxide system modulation, while TB-500 accelerates cell migration via actin regulation and provides anti-inflammatory activity through NF-kB suppression. The 5mg format is suited for smaller-scale research protocols or studies requiring less total peptide material. Both components maintain their individual mechanisms of action when combined. See the Wolverine Blend 10mg entry for comprehensive research details on the BPC-157/TB-500 combination rationale.
Mechanism of Action
The Wolverine Blend 5mg is a lower-quantity formulation of the same BPC-157/TB-500 combination available in the 10mg vial. The synergistic rationale remains identical: BPC-157 promotes angiogenesis through VEGF upregulation and nitric oxide system modulation, while TB-500 accelerates cell migration via actin regulation and provides anti-inflammatory activity through NF-kB suppression. The 5mg format is suited for smaller-scale research protocols or studies requiring less total peptide material. Both components maintain their individual mechanisms of action when combined. See the Wolverine Blend 10mg entry for comprehensive research details on the BPC-157/TB-500 combination rationale.
Key Research Findings
- Sikiric et al. (2018) demonstrated BPC-157 promotes angiogenesis and cytoprotection through VEGF and NO system modulation.
- Bock-Marquette et al. (2004) showed thymosin beta-4 promotes cell survival and migration through Akt activation.
- Chang et al. (2011) found BPC-157 accelerates tendon healing through fibroblast outgrowth and VEGF expression.
- Malinda et al. (1999) demonstrated TB4 accelerates wound healing by promoting cell migration.
Citations & References
Stable gastric pentadecapeptide BPC 157 and wound healing
Sikiric P, Hahm KB, Blagaic AB, et al. — Front Pharmacol (2018)
Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair
Bock-Marquette I, Saxena A, White MD, et al. — Nature (2004)
Thymosin beta4 accelerates wound healing
Malinda KM, Sidhu GS, Mani H, et al. — J Invest Dermatol (1999)
Dosage in Research
Blend dosing references individual component research. BPC-157: 10 mcg/kg in animals. TB-500: 10 mg loading dose in equine studies. The 5mg vial is appropriate for smaller-scale protocols.
Dosage information is derived from published research literature and is presented for educational purposes only. This is not medical advice. All products are for laboratory research use only.
Storage & Handling
Store lyophilized (freeze-dried) powder at -20°C to 4°C in a dry environment protected from light. Unreconstituted peptide is stable for extended periods when stored properly.
Once reconstituted with bacteriostatic water or an appropriate solvent, store at 2-8°C and use within the timeframe specified on the Certificate of Analysis. Avoid repeated freeze-thaw cycles.
A Certificate of Analysis documenting purity, identity, and recommended storage conditions is included with every order.
Frequently Asked Questions
What is Wolverine Blend 5mg?
What purity is your Wolverine Blend 5mg?
How should I store Wolverine Blend 5mg?
Is Wolverine Blend 5mg for human use?
Where can I buy Wolverine Blend 5mg?
Research Use Only
All products are intended for laboratory research and educational purposes only. Products have not been evaluated by the FDA and are not intended for human consumption, diagnosis, treatment, or prevention of any disease. Purchasers must be 21+ and confirm research use intent.